Microsomal Prostaglandin E Synthase-1–Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2016-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.115.306642PMID 26543101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COX2 Inhibition Reduces Aortic Valve Calcification In Vivo

  2015cited by this paper
• Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.

  2015cited by this paper
• Cardiovascular calcification: current controversies and novel concepts.

  2015cited by this paper
• Calcification in Aortic Stenosis: The Skeleton Key.

  2015cited by this paper
• Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice

  2014cited by this paper
• Prostaglandin E2 inhibits in-vitro mineral deposition by human periodontal ligament cells via modulating the expression of TWIST1 and RUNX2.

  2014cited by this paper
• A novel model of adenine-induced tubulointerstitial nephropathy in mice

  2013cited by this paper
• Cyclooxygenase-2–Derived Prostaglandin E2 Promotes Injury-Induced Vascular Neointimal Hyperplasia Through the E-prostanoid 3 Receptor

  2013cited by this paper
• Vascular Calcification: An Update on Mechanisms and Challenges in Treatment

  2013cited by this paper
• Cell Selective Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1

  2013cited by this paper
• The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis

  2013cited by this paper
• Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets.

  2012cited by this paper
• Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification

  2012cited by this paper
• Cyclooxygenase-2 and kidney failure.

  2012cited by this paper
• Cardiovascular Risk in Rheumatoid Arthritis: Pathogenesis, Diagnosis, and Management

  2012cited by this paper
• Upregulation of Cyclooxygenase-2 (COX-2) and Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) in Wall of Ruptured Human Cerebral Aneurysms: Preliminary Results

  2012cited by this paper
• Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

  2011cited by this paper
• Microsomal Prostaglandin E2 Synthase-1 Modulates the Response to Vascular Injury

  2011cited by this paper
• Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2

  2011cited by this paper
• Targeted Disruption of the Prostaglandin E2 E-Prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice

  2011influential reference
• Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

  2011cited by this paper
• Regulatory mechanisms in vascular calcification

  2010cited by this paper
• Prostaglandins in bone: bad cop, good cop?

  2010cited by this paper
• Time for a comeback of NSAIDs in proteinuric chronic kidney disease?

  2010cited by this paper
• Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1

  2010cited by this paper
• Cardiovascular biology of microsomal prostaglandin E synthase-1.

  2010influential reference
• Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events

  2010cited by this paper
• Increased bone mass in adult prostacyclin-deficient mice.

  2010cited by this paper
• Laminar Shear Stress Regulates Liver X Receptor in Vascular Endothelial Cells

  2008cited by this paper
• Microsomal prostaglandin E synthase‐1 inhibition in cardiovascular inflammatory disease

  2008cited by this paper
• Continuous PGE 2 leads to net bone loss while intermittent PGE 2 leads to net bone gain in lumbar vertebral bodies of adult female rats

  2008cited by this paper
• Microsomal Prostaglandin E Synthase-1 Deletion Suppresses Oxidative Stress and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation

  2008cited by this paper
• Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.

  2008cited by this paper
• Vascular calcification: pathobiology of a multifaceted disease.

  2008cited by this paper
• Prostaglandin E2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the EP4 pathway.

  2008cited by this paper
• Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

  2007cited by this paper
• Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells

  2007cited by this paper
• Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis

  2006cited by this paper
• Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials.

  2006cited by this paper
• Vascular Calcification: Pathobiological Mechanisms and Clinical Implications

  2006cited by this paper
• Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections.

  2005cited by this paper
• COX-2–Derived Prostacyclin Modulates Vascular Remodeling

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• Coxibs and cardiovascular disease.

  2004cited by this paper
• Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin.

  2004cited by this paper
• Deletion of Microsomal Prostaglandin E2 (PGE2) Synthase-1 Reduces Inducible and Basal PGE2 Production and Alters the Gastric Prostanoid Profile*

  2004cited by this paper
• Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis.

  2003cited by this paper
• Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2

  2002cited by this paper
• Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E2-Dependent Plaque Instability

  2001cited by this paper
• Runt Domain Factor (Runx)-dependent Effects on CCAAT/ Enhancer-binding Protein δ Expression and Activity in Osteoblasts*

  2000cited by this paper
• The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

  2000cited by this paper
• Impaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice*

  2000cited by this paper
• Pharmacological analysis of cyclooxygenase-1 in inflammation.

  1998cited by this paper
• Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells.

  1997cited by this paper
• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

  1993cited by this paper
• THE SMOOTH MUSCLE CELL

  1971cited by this paper

• Proton pump inhibitors accelerate vascular calcification via COX-2-mediated mitophagy inhibition in chronic kidney disease.

  2026cites this paper
• Runx2-NLRP3 Axis Orchestrates Matrix Stiffness-evoked Vascular Smooth Muscle Cell Inflammation.

  2025cites this paper
• Nesfatin-1 enhances vascular smooth muscle calcification through facilitating BMP-2 osteogenic signaling

  2024influential citation
• CD8+ T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis

  2024cites this paper
• Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease

  2023cites this paper
• Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

  2023cites this paper
• Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification

  2023cites this paper
• Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells

  2023cites this paper
• Synthesis of rare-earth metal-organic frameworks to construct high-resolution sensing array for multiplex anions detection, cell imaging and blood phosphorus monitoring.

  2023cites this paper
• Shh-Gli2-Runx2 inhibits vascular calcification.

  2023cites this paper
• A narrative review of research advances in hypoxic pulmonary hypertension

  2022cites this paper
• Association between serum alpha-Klotho and severe abdominal aortic calcification among civilians in the United States.

  2022cites this paper
• Inflammation: a putative link between phosphate metabolism and cardiovascular disease.

  2021cites this paper
• A multi-omics view of the complex mechanism of vascular calcification.

  2021cites this paper
• ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.

  2021cites this paper
• Unspliced XBP1 Counteracts β-Catenin to Inhibit Vascular Calcification

  2021cites this paper
• Omics Research in Vascular Calcification.

  2020cites this paper
• Omics Research in Vascular Calcification.

  2020cites this paper
• Seaweed Porphyra yezoensis polysaccharides with different molecular weights inhibit hydroxyapatite damage and osteoblast differentiation of A7R5 cells.

  2020cites this paper
• Regulation of mineralisation in bone and vascular tissue: a comparative review.

  2020cites this paper
• CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling.

  2019cites this paper
• AT2 receptor stimulation inhibits phosphate-induced vascular calcification.

  2019cites this paper
• Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression

  2019cites this paper
• BMP9/COX‐2 axial mediates high phosphate‐induced calcification in vascular smooth muscle cells via Wnt/β‐catenin pathway

  2018cites this paper
• Biochemical Alterations in Hypervitaminosis D3 in Broiler Chicks Concomitantly Challenged with Endotoxin. J. World Poult. Res., 8 (4): 100-104. http://jwpr.science-line.com;

  2018influential citation
• Reporting Sex and Sex Differences in Preclinical Studies.

  2018cites this paper
• Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications

  2018cites this paper
• BMP 9 / COX-2 axial mediates high phosphate-induced calcification in vascular smooth muscle cells via Wnt / β-catenin pathway † Running title : BMP 9 / COX-2 and vascular smooth muscle cells calcification

  2017cites this paper
• Vascular Smooth Muscle Cells.

  2016cites this paper
• Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification.

  2016cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology

  year unknowncites this paper
• Research progress in relationship between prostaglandin E 2 and cardiovascular diseases

  year unknowncites this paper